Surface Oncology Inc - Company Profile

Powered by

All the data and insights you need on Surface Oncology Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Surface Oncology Inc Strategy Report

  • Understand Surface Oncology Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Surface Oncology Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Surface Oncology Inc (Surface Oncology) is an immuno-oncology company. It develops novel antibody therapies for the treatment of cancer. The company’s product portfolio includes SRF388, to treat various diseases like renal cell carcinoma, hepatocellular carcinoma, and non-small-cell lung cancer, SRF617, to treat various tumors like gastric cancer, prostate cancer, PD-(L)1 relapsed cancer, and pancreatic cancer. Surface Oncology also provides SRF114, NZV930 and GSK4381562 antibodies. It also carries out research and development activities and pre-clinical studies. The company has collaborations to advance our next-generation cancer therapies partners which include Novartis and GSK. Surface Oncology is headquartered in Cambridge, Massachusetts, the US.

 Gain a 360-degree view of Surface Oncology Inc and make more informed decisions for your business Gain a 360-degree view of Surface Oncology Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 50 Hampshire Street, 8th Floor, Cambridge, Massachusetts, 02139
Website www.surfaceoncology.com
Telephone 1 617 7144096
No of Employees 60
Industry Pharmaceuticals and Healthcare
Revenue (2022) $30.0M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Surface Oncology Inc premium industry data and analytics

20+

Catalyst Calendar

Proactively evaluate Surface Oncology Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Pipeline Drugs

Identify which of Surface Oncology Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

11+

Clinical Trials

Determine Surface Oncology Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Investigators

Review investigator profiles and find information on trial contacts across Surface Oncology Inc, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Services
Pipeline Pre-Clinical Studies
SRF388 - Hepatocellular Carcinoma and Non-Small-Cell Lung Cancer Research and Development
SRF114 - Solid Tumors
XYZ
XYZ
XYZ
Understand Surface Oncology Inc portfolio and identify potential areas for collaboration Understand Surface Oncology Inc portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Surface Oncology Inc Merck & Co Inc AbbVie Inc AstraZeneca Plc Bristol-Myers Squibb Co
Headquarters United States of America United States of America United States of America United Kingdom United States of America
City Cambridge Rahway North Chicago Cambridge Princeton
State/Province Massachusetts New Jersey Illinois England New Jersey
No. of Employees 60 72,000 50,000 89,900 34,100
Entity Type Private Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Executives
Name Position Board Since Age
Denice Torres Chairman Executive Board 2021 -
Robert W. Ross, M.D. Director; Chief Executive Officer Executive Board 2021 -
Jessica Fees Chief Financial Officer Senior Management 2021 -
Lisa McGrath Chief People Officer Senior Management - -
Alison O’Neill, M.D. Chief Medical Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Surface Oncology Inc key executives to enhance your sales strategy Gain insight into Surface Oncology Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer